Work

Bone marrow next generation sequencing minimal residual disease (NGS-MRD) positivity pre-allogeneic hematopoietic cell transplantation (HCT) predicts outcomes for patients with B-cell acute lymphoblastic leukemia (B-ALL): A planned analysis from the ptctc ONC1401 trial

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-511

Authors: Amanda Johnson, Yuxin Zhao, Xi Qiao, J. Gregory Dolan, Karely Van Thiel Berghuijs, Julie-An Talano, Carrie Kitko, Sonali Chaudhury, Christopher Dvorak, Nahal Lalefar, Nancy Bunin, Neena Kapoor, Eric Anderson, Alice Bertaina, Allyson Flower, Michael Pulsipher, Hisham Abdel-Azim

Institutions: Intermountain Healthcare, Primary Children's Hospital, University of Utah, Huntsman Cancer Institute, Medical College of Wisconsin, Vanderbilt University, Vanderbilt University Medical Center, Northwestern University, Lurie Children's Hospital, University of California, San Francisco, UCSF Benioff Children's Hospital, Children's Hospital of Philadelphia, Children's Hospital of Los Angeles, Rady Children's Hospital-San Diego, Lucile Packard Children's Hospital, Stanford University, New York Medical College

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417014128

Cites:

Cited by:

Related to: